Sectorial iris infarction caused by meningococcal septicaemia.
Kennedy
C J
CJ
Department of Ophthalmology, Princess Margaret Hospital, Subiaco, Western Australia.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000209:etiology* / Q000628:therapy; D003229:Conjunctival Diseases / Q000209:etiology / Q000628:therapy; D004211:Disseminated Intravascular Coagulation / Q000209:etiology / Q000628:therapy; D015818:Eye Infections, Bacterial / Q000209:etiology* / Q000628:therapy; D005654:Fundus Oculi; D006470:Hemorrhage / Q000209:etiology / Q000628:therapy; D006801:Humans; D007223:Infant; D007238:Infarction / Q000382:microbiology* / Q000628:therapy; D007498:Iris / Q000098:blood supply*; D008297:Male; D008585:Meningitis, Meningococcal / Q000209:etiology / Q000628:therapy; D008589:Meningococcal Infections / Q000209:etiology* / Q000628:therapy; D009345:Neisseria meningitidis / Q000302:isolation & purification; D010956:Plasmapheresis; D012871:Skin Diseases / Q000209:etiology / Q000628:therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D010959:Tissue Plasminogen Activator